TNG-917

N/A

Report date: 2024/07/08 17:14:35

Base Information

Drug NameTNG-917
Drug Alias NameTNG-917TNG917
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EHMT2 inhibitorsEuchromatic Histone Lysine Methyltransferase 1 modulators
TargetsHistone-lysine N-methyltransferase EHMT2Euchromatic Histone Lysine Methyltransferase 1
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTango Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTango Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A